RAG8 peptide is an antagonist for protease-activated receptor 4 ( PAR 4 ), which inhibits late-stage platelet activation, and reduces thrombosis without altering hemostasis or increasing bleeding risk. RAG8 peptide can be used for atherosclerosis research.